With its Bristol Myers-partnered CAR-T therapy under FDA review, bluebird bio is getting a $200 million payout. The Big Pharma is forking over the cash to get out of future payments on the treatment outside the U.S.. The duo retooled their deal to focus on the …
See Original Article

(CNN) — After weeks working in New York City hospitals on the front lines of the coronavirus pandemic, the time had finally come for Dr. Ethan Weiss to head home. But the University of California, San Francisco, cardiologist was surprised by what he saw …
See Original Article

As a number of startups get back into fundraising in earnest, one that is on a growth tear has closed a substantial debt round to hold on to more equity in the company as it inches to being cash-flow positive. MemSQL — the relational, real-time database used …
See Original Article

The UK could legalize electric scooters by June 2020. Transport secretary Grant Shapps said during Sunday’s government press conference; Silicon Valley scooter firms such as Bird and Lime have lobbied for scooter schemes to be permitted in the UK since …
See Original Article

Stock-index futures pointed to a softer start for Wall Street Monday after equities ended last week on a strong note, with investors looking past a surge in unemployment that pushed the unemployment rate soaring.
See Original Article